Brief: Ascelia Pharma: Second US Patent For Oncoral Strengthens Coverage
31/05/2022 07:10
May 31 (Reuters) - Ascelia Pharma AB ACELP.ST :
* US PATENT AND TRADEMARK OFFICE HAS ISSUED NOTICE OF
ALLOWANCE
FOR SECOND ONCORAL PATENT APPLICATION COVERING METHOD OF USE OF
ONCORAL
* NEW PATENT FURTHER STRENGTHENS INTELLECTUAL PROPERTY
PROTECTION
FOR ONCORAL AND PROVIDES PROTECTION UNTIL 2035 IN US
Source text for Eikon: ID:nMFN5vFTYY
Further company coverage: ACELP.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))